|
"The Merck Way" Presented in a New Image Brochure and Film
|
17 September 2010 |
|
Merck's Cladribine Tablets for Multiple Sclerosis Approved in Australia
|
03 September 2010 |
|
FDA Grants Priority Review to Cladribine Tablets
|
29 July 2010 |
|
Merck Resubmits U.S. Application for Cladribine Tablets
|
08 June 2010 |
|
Stimuvax Clinical Program Temporarily Suspended
|
25 March 2010 |
|
Merck KGaA Receives Refuse to File Letter from FDA on Cladribine Tablets New Drug Application
|
02 December 2009 |
|
Merck KGaA to Expand Research and Development Presence in China
|
24 November 2009 |
|
Merck Revenues Increase by 2.7% to € 1.9 Billion
|
27 October 2009 |
|
Merck Submits Application for Cladribine Tablets
|
01 October 2009 |
|
Q2/2009: Merck Revenues Remain Steady at € 1.9 Billion
|
27 July 2009 |
|
Q1/2009: Merck Revenues Remain Stable at € 1.9 Billion
|
28 April 2009 |
|
Merck KGaA and Fast Forward, LLC Announce Collaboration
|
19 March 2009 |
|
The safety of patients is of utmost importance to Merck
|
21 February 2009 |